Tutorials
TSX:NVCN (Canada)  
Neovasc Inc logo

Neovasc Inc

C$ 10.20 (+2%) Aug 5
P/E:
At Loss
P/B:
0.50
Market Cap:
C$ 27.84M ($ 21.52M)
Enterprise V:
C$ -12.93M ($ -10.00M)
Volume:
2.41K
Avg Vol (2M):
888.00
Also Trade In:
Volume:
2.41K
Market Cap C$:
27.84M
Market Cap $:
21.52M
PE Ratio:
At Loss
Avg Vol (2-Month):
888.00
Enterprise Value C$:
-12.93M
Enterprise Value $:
-10.00M
PB Ratio:
0.50
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Neovasc Inc
NAICS : 339112 SIC : 3741
13562 Maycrest Way, Suite 5138, Richmond, BC, CAN, V6V 2J7
Description
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.
Name Current Vs Industry Vs History
Cash-To-Debt 3.54
Equity-to-Asset 0.73
Debt-to-Equity 0.29
Debt-to-EBITDA -0.4
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.07
Distress
Grey
Safe
Beneish M-Score -3.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 97.9
9-Day RSI 92.64
14-Day RSI 84.7
6-1 Month Momentum % -42.18
12-1 Month Momentum % -70

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.88
Quick Ratio 12.5
Cash Ratio 11.86
Days Inventory 796.46
Days Sales Outstanding 84.26
Days Payable 835.2

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -189

Financials (Next Earnings Date:2022-08-10 Est.)

TSX:NVCN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 3.409
EPS (TTM) (C$) -15.083
Beta 1.99
Volatility % 58.8
14-Day RSI 84.7
14-Day ATR (C$) 0.262682
20-Day SMA (C$) 8.494
12-1 Month Momentum % -70
52-Week Range (C$) 6 - 27
Shares Outstanding (Mil) 2.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neovasc Inc Filings

Document Form Filing Date
No Filing Data